CLEAN3 clinical trial outlines potential new best practices for peripheral IV catheters - Video Summary

Professor Olivier Mimoz, head of the emergency department at Hôpital Universitaire de Poitiers, France, and principal investigator of the CLEAN3 trial, summarizes the results of the trial published in the Lancet Infectious Diseases. The trial showed that the use of the BD vascular care solution resulted in fewer PIVC failures compared with the standard group (34.8% vs. 47.5%. respectively) and extended the median time between catheter insertion and failure (50.4 hours vs 30.0 hours, respectively).

February 6, 2023